628 results on '"Goldberg, Judith D."'
Search Results
52. MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis
53. Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus
54. Rapid Number Naming and Quantitative Eye Movements May Reflect Contact Sport Exposure in a Collegiate Ice Hockey Cohort
55. Increasing Use of the Vaccine Against Zoster Through Recommendation and Administration by Ophthalmologists at a City Hospital
56. Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis
57. Examination of speakership gender disparity at an international oncology conference.
58. Natalizumab Extended Interval Dosing (EID) is Associated with a Reduced Risk of Progressive Multifocal Leukoencephalopathy (PML) Compared With Every-4-Week (Q4W) Dosing: Updated Analysis of the TOUCH® Prescribing Program Database (P13-4.010)
59. A Note on Monotonicity Assumptions for Exact Unconditional Tests in Binary Matched-Pairs Designs
60. Impact of Socioeconomic Status and Sociodemographic Factors on Melanoma Presentation Among Ethnic Minorities
61. Outcomes of coronary artery bypass grafting and reduction annuloplasty for functional ischemic mitral regurgitation: A prospective multicenter study (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve)
62. Adherence to guidelines at the patient‐ and hospital‐levels is associated with improved overall survival in patients with gastric cancer
63. Proactive Approach to Lymphedema Risk Reduction: A Prospective Study
64. A panoramic view of the skull base: systematic review of open and endoscopic endonasal approaches to four tumors
65. Reducing Ptcy Dose in Patients Receiving CAST for GvHD Prevention Results in Accelerated Engraftment at the Cost of Higher Incidence of GvHD
66. Elevated Levels of Urinary Biomarkers TIMP-2 and IGFBP-7 Predict Acute Kidney Injury in Neonates after Congenital Heart Surgery
67. CD4⁺ T Cell Surface CCR5 Density and Virus Load in Persons Infected with Human Immunodeficiency Virus Type 1 [with Reply]
68. Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms
69. The Evaluation of Medical Screening Procedures
70. The Effects of Misclassification on the Bias in the Difference Between Two Proportions and the Relative Odds in the Fourfold Table
71. Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival
72. Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma
73. Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients
74. Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial.
75. S-Adenosylmethionine as a Biomarker for the Early Detection of Lung Cancer
76. Histologic features are important prognostic indicators in early stages lung adenocarcinomas
77. Fludrocortisone in patients with familial dysautonomia: Assessing effect on clinical parameters and gene expression
78. Natalizumab Extended Interval Dosing (EID) is Associated with a Reduced Risk of Progressive Multifocal Leukoencephalopathy (PML) Compared with Every-4-week (Q4W) Dosing: Updated Analysis of the TOUCH® Prescribing Program Database (4419)
79. A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF)
80. Evaluation of pro-carboxypeptidase A and carboxypeptidase A as serologic markers for adenocarcinoma of the pancreas
81. Prone vs Supine Positioning for Breast Cancer Radiotherapy
82. Meta-Analysis to Assess the Appropriate Endpoint for Slow Pathway Ablation of Atrioventricular Nodal Reentrant Tachycardia
83. The LUCINDA trial: Leuprolide + cholinesterase inhibition to reduce neurologic decline in Alzheimer's
84. Progression free survival (PFS) in Asian vs non-Asian patients (pts) with EGFR mutant non-small cell lung cancer (NSCLC) receiving osimertinib.
85. A phase I/II multisite study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC).
86. Agent of Opportunity Risk Mitigation: People, Engineering, and Security Efficacy
87. Examining Nurses’ Decision Process for Medication Management in Home Care
88. Additional file 1 of Value of metalloproteinases in predicting COPD in heavy urban smokers
89. Helicobacter pylori and Overweight Status in the United States: Data from the Third National Health and Nutrition Examination Survey
90. Lack of major involvement of human uroplakin genes in vesicoureteral reflux: Implications for disease heterogeneity
91. Survival in familial dysautonomia: Impact of early intervention
92. Lung-Specific Expression of Dominant-Negative Mutant p53 in Transgenic Mice Increases Spontaneous and Benzo(a)pyrene-Induced Lung Cancer
93. Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications
94. Risk of Malignancy in Follicular Neoplasms without Nuclear Atypia: Statistical Analysis of 397 Thyroidectomies
95. ATIM-37. PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RADIATION (HFRT) FOR ADULT PATIENTS WITH SECONDARILY TRANSFORMED IDH-MUTANT GLIOBLASTOMA (GBM)
96. Plasma Zonulin Levels in Childhood Nephrotic Syndrome
97. Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the TOUCH® Prescribing Program
98. Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers
99. Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence
100. A multifactorial trial design to assess combination therapy in hypertension: treatment with bisoprolol and hydrochlorothiazide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.